Search Results - "K. Usuki"

Comparable outcomes between autologous and allogeneic transplant for adult acute myeloid leukemia in first CR by Mizutani, M, Hara, M, Fujita, H, Aoki, J, Kanamori, H, Ohashi, K, Usuki, K, Fukuda, T, Chou, T, Tanaka, J, Atsuta, Y, Takami, A

“…Although allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor (MSD) is a potentially curative post-remission treatment for…”
Get full text

Complex molecular genetic abnormalities involving three or more genetic mutations are important prognostic factors for acute myeloid leukemia by Wakita, S, Yamaguchi, H, Ueki, T, Usuki, K, Kurosawa, S, Kobayashi, Y, Kawata, E, Tajika, K, Gomi, S, Koizumi, M, Fujiwara, Y, Yui, S, Fukunaga, K, Ryotokuji, T, Hirakawa, T, Arai, K, Kitano, T, Kosaka, F, Tamai, H, Nakayama, K, Fukuda, T, Inokuchi, K

“…We conducted a comprehensive analysis of 28 recurrently mutated genes in acute myeloid leukemia (AML) in 271 patients with de novo AML. Co-mutations were…”
Get full text

Spectrum of clinical and genetic features of patients with inherited platelet disorder with suspected predisposition to hematological malignancies: a nationwide survey in Japan by Yoshimi, A., Toya, T., Nannya, Y., Takaoka, K., Kirito, K., Ito, E., Nakajima, H., Hayashi, Y., Takahashi, T., Moriya-Saito, A., Suzuki, K., Harada, H., Komatsu, N., Usuki, K., Ichikawa, M., Kurokawa, M.

“…Inherited thrombocytopenia (IT) contains several forms of familial thrombocytopenia and some of them have propensity to hematological malignancies. The…”
Get full text

Three-dimensional surface figure measurement of high-accuracy spherical mirror with nanoprofiler using normal vector tracing method by Kudo, R, Okuda, K, Usuki, K, Nakano, M, Yamamura, K, Endo, K

“…Processing technology using an extreme ultraviolet light source, e.g., next-generation lithography, requires next-generation high-accuracy mirrors. As it will…”
Get more information

Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy by Tanaka, M, Kanamori, H, Matsumoto, K, Tachibana, T, Numata, A, Ohashi, K, Kobayashi, T, Nakaseko, C, Kanda, Y, Yamazaki, E, Fujisawa, S, Ooi, J, Sakura, T, Aotsuka, N, Onoda, M, Machida, S, Kato, J, Usuki, K, Watanabe, R, Taguchi, J, Yano, S, Saito, T, Takahashi, S, Sakamaki, H, Okamoto, S

“…This prospective study aimed to investigate the influence of pretransplant serum ferritin levels on the outcomes of allogeneic hematopoietic SCT (HSCT). In…”
Get full text

THE PROGNOSTIC IMPACT OF ERYTHROID DYSPLASIA IN APLASTIC ANEMIA AND MYELODYSPLASTIC NEOPLASMS WITH SINGLE-LINEAGE DYSPLASIA by Maeda, T., Matsuda, A., Kanda, J., Kawabata, H., Ishikawa, T., Tohyama, K., Kitanaka, A., Araseki, K., Shimbo, K., Hata, T., Suzuki, T., Kayano, H., Usuki, K., Shindo-Ueda, M., Arima, N., Nohgawa, M., Ohta, A., Chiba, S., Miyazaki, Y., Nakao, S., Ozawa, K., Arai, S., Kurokawa, M., Takaori-Kondo, A., Mitani, K.

“…While genetic aberrations are becoming increasingly critical in disease classification, morphological abnormalities defined by a 10% threshold in each lineage…”
Get full text

P1007: PHASE 2, OPEN‐LABEL, MULTICENTER, SINGLE‐ARM STUDY INVESTIGATING THE EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA‐2B IN JAPANESE PATIENTS WITH POLYCYTHEMIA VERA by Kirito, K., Edahiro, Y., Ohishi, K., Gotoh, A., Takenaka, K., Shibayama, H., Shimizu, T., Usuki, K., Shimoda, K., Ito, M., VanWart, S. A., Zagrijtschuk, O., Qin, A., Kawase, H., Miyachi, N., Sato, T., Komatsu, N.

Get full text

P830: CROVALIMAB MAINTAINS CLINICAL BENEFIT OVER LONG‐TERM TREATMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM THE COMPOSER TRIAL OPEN‐LABEL EXTENSION by Röth, A., Egyed, M., Ichikawa, S., Ito, Y., Kim, J. S., Nagy, Z., Obara, N., Panse, J., Schrezenmeier, H., Sica, S., Soret, J., Usuki, K., Yoon, S.‐S., Benkali, K., Buri, M., Lundberg, P., Patel, H., Shinomiya, K., Sreckovic, S., Nishimura, J.‐I.

Get full text

P827: EFFICACY AND SAFETY OF ROMIPLOSTIM ADDED TO IMMUNOSUPPRESSIVE THERAPY AS A FIRST‐LINE TREATMENT IN PATIENTS WITH APLASTIC ANEMIA: A PHASE 2/3 CLINICAL TRIAL by Yamazaki, H., Lee, J. W., Jang, J. H., Sawa, M., Kizaki, M., Tomiyama, Y., Nagafuji, K., Usuki, K., Gau, J.‐P., Morita, Y., Tang, J.‐L., Chang, H., Noshiro, M., Matsuda, A., Ozawa, K., Mitani, K., Kanda, Y., Nakao, S.

Get full text

Effect of related donor availability on outcome of AML in the context of related and unrelated hematopoietic cell transplantation by Yanada, M, Kurosawa, S, Yamaguchi, T, Uchida, N, Miyawaki, S, Kanamori, H, Usuki, K, Kobayashi, T, Watanabe, M, Nagafuji, K, Yano, S, Nawa, Y, Tomiyama, J, Tashiro, H, Nakamura, Y, Fujisawa, S, Kimura, F, Emi, N, Miura, I, Fukuda, T

“…Although allogeneic hematopoietic cell transplantation (HCT) from a related donor is effective therapy for younger patients with AML, it remains unknown how…”
Get full text

P744: UNBALANCED TRANSLOCATION DER(1;7)(Q10;P10) AS A DISTINCT SUBTYPE IN MYELODYSPLASTIC SYNDROMES by Okuda, R., Ochi, Y., Chonabayashi, K., Hiramoto, N., Sanada, M., Handa, H., Kasahara, S., Sato, S., Kanemura, N., Kitano, T., Watanabe, M., Kern, W., Creignou, M., Shiraishi, Y., Watanabe, M., Usuki, K., Imashuku, S., Hellstrom‐Lindberg, E., Haferlach, T., Chiba, S., Sezaki, N., Shih, L.‐Y., Miyazaki, Y., Yoshida, Y., Ishikawa, T., Ohyashiki, K., Atsuta, Y., Shiozawa, Y., Miyano, S., Makishima, H., Nannya, Y., Ogawa, S.

Get full text

RESULTS OF THE PEGASUS PHASE 3 RANDOMIZED TRIAL DEMONSTRATING SUPERIORITY OF THE C3 INHIBITOR PEGCETACOPLAN COMPARED TO ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA by H. Weitz, P. Hillmen, J. Szer, A. Röth, B. Höchsmann, J. Panse, K. Usuki, M. Griffin, J. Kiladjian, C. Decastro, H. Nishimori, L. Tan, M. Hamdani, P. Deschatelets, C. Francois, F. Grossi, A. Risitano, R.P. Latour

Get full text

P466: AMPLIFIED EPOR/JAK2 GENES DEFINE A UNIQUE SUBTYPE OF ACUTE ERYTHROID LEUKEMIA by Takeda, J., Yoshida, K., Nakagawa, M., Nannya, Y., Yoda, A., Saiki, R., Ochi, Y., Zhao, L., Okuda, R., Qi, X., Mori, T., Kon, A., Chiba, K., Tanaka, H., Shiraishi, Y., Kuo, M.‐C., Kerr, C., Nagata, Y., Morishita, D., Hiramoto, N., Hangaishi, A., Nakazawa, H., Ishiyama, K., Miyano, S., Chiba, S., Miyazaki, Y., Kitano, T., Usuki, K., Sezaki, N., Tsurumi, H., Miyawaki, S., Maciejewski, J., Ishikawa, T., Ohyashiki, K., Ganser, A., Heuser, M., Thol, F., Shih, L.‐Y., Takaori−Kondo, A., Makishima, H., Ogawa, S.

Get full text

Effects of a laser beam profile to measure an aspheric mirror on a high-speed nanoprofiler using normal vector tracing method by Matsumura, H., Tonaru, D., Kitayama, T., Usuki, K., Kojima, T., Uchikoshi, J., Higashi, Y., Endo, K.

“…In order to develop the next generation of ultraprecision aspheric mirrors, a high-speed nanoprofiler is indispensable. We have developed a new version of such…”
Get full text

Prophylactic impact of imatinib administration after allogeneic stem cell transplantation on the incidence and severity of chronic graft versus host disease in patients with Philadelphia chromosome-positive leukemia by Nakasone, H, Kanda, Y, Takasaki, H, Nakaseko, C, Sakura, T, Fujisawa, S, Yokota, A, Yano, S, Usuki, K, Maruta, A, Abe, D, Hoshino, T, Takahashi, S, Kanamori, H, Okamoto, S

Get full text

Effect of the order of TBI and cyclophosphamide administration on the outcome of allogeneic hematopoietic stem cell transplantation by Motohashi, K, Fujisawa, S, Onizuka, M, Kako, S, Sakaida, E, Shono, K, Tatara, R, Doki, N, Mori, T, Sakura, T, Aotsuka, N, Fuji, E, Tomita, N, Kawai, N, Saitoh, T, Usuki, K, Taguchi, J, Watanabe, R, Kobayashi, S, Yano, S, Kanamori, H, Takahashi, S, Okamoto, S

Get full text

One-year low-dose valacyclovir as prophylaxis for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. A prospective study of the Japan Hematology and Oncology Clinical Study Group by Oshima, K., Takahashi, T., Mori, T., Matsuyama, T., Usuki, K., Asano-Mori, Y., Nakahara, F., Okamoto, S., Kurokawa, M., Kanda, Y.

“…K. Oshima, T. Takahashi, T. Mori, T. Matsuyama, K. Usuki, Y. Asano‐Mori, F. Nakahara, S. Okamoto, M. Kurokawa, Y. Kanda. One‐year low‐dose valacyclovir as…”
Get full text

POST-AZACITIDINE CLONE SIZE PREDICTS LONG-TERM OUTCOME OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND RELATED MYELOID NEOPLASMS by Nannya, Y., Tobiasson, M., Sato, S., Bernard, E., Ohtake, S., Takeda, J., Creignou, M., Kusakabe, M., Shibata, Y., Nakamura, N., Watanabe, M., Hiramoto, N., Shiozawa, Y., Shiraishi, Y., Tanaka, H., Yoshida, K., Kakicuchi, N., Makishima, H., Nakagawa, M., Usuki, K., Watanabe, M., Imada, K., Handa, H., Taguchi, M., Kiguchi, T., Ohyashiki, K., Ishikawa, T., Takaori, A., Tsurumi, H., Kasahara, S., Chiba, S., Naoe, T., Miyano, S., Papaemmanuil, E., Miyazaki, Y., Hellstrom-Lindberg, E., Ogawa, S.

Get full text

Pancreatic atrophy is associated with gastrointestinal chronic GVHD following allogeneic PBSC transplantation by Nakasone, H, Ito, A, Endo, H, Kida, M, Koji, I, Usuki, K

Get full text

Design of Ni Mold for Discrete Track Media by Ichikawa, K., Usa, T., Nishimaki, K., Usuki, K.

“…Nano imprint lithography (NIL) and NIL mold formation play a vital role in discrete track media (DTM) production. In this paper, we created a nickel (Ni) mold…”
Get full text